Eisai Co (STU:EII) FFO


STU:EII Eisai Co Ltd STU:EII
74 GF Score
Price €20.91
GF Value €31.81
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Eisai Co FFO?

FFO (Funds from operations) only applies to REITs.

STU:EII
74GF Score
Eisai Co Ltd STU:EII
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Eisai Co (STU:EII) Overvalued in 2026?

Based on GuruFocus' analysis, Eisai Co stock appears to be undervalued. The current stock price of €20.91 is trading 34.3% below its estimated GF Value™ of €31.81. GuruFocus considers Eisai Co to be Significantly Undervalued.

Key valuation signals for STU:EII:

  • FFO:
  • GF Value™: €31.81 vs. price of €20.91 (34.3% below fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the STU:EII stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eisai Co Business Description

Address 4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of research and development, manufacturing, sales, import, and export of pharmaceuticals. The pharmaceutical business is categorized by region, including East Asia & Global South; Europe, Middle East, Africa, Russia, Oceania (EMEA); Americas; China; and Japan. The company also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived from its American pharmaceutical business, followed by its Japanese pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.
74GF Score

Get the complete analysis for STU:EII

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.91
Price
€31.81
GF Value